Literature DB >> 26282900

Nasopharyngeal carcinoma with intracranial extension in the era of intensity-modulated radiotherapy: case-control study using propensity score matching method.

Cai-Neng Cao1,2,3, Jing-Wei Luo4, Li Gao1, Guo-Zhen Xu1, Jun-Lin Yi1, Xiao-Dong Huang1, Su-Yan Li1, Jian-Ping Xiao1, Zhong Zhang1.   

Abstract

The objective of the study was to evaluate long-term survival outcomes and toxicity of T4 classification nasopharyngeal carcinoma (NPC) with intracranial extension (IE group) or without intracranial extension (non-IE group) after intensity-modulated radiotherapy (IMRT) using the propensity score matching method. After generating propensity scores given the covariates of age, sex, N classification, and concurrent chemotherapy, 132 patients in each group were matched. The 5-year local failure-free survival rate and the 5-year overall survival rate in the IE group were lower than the patients in the non-IE group (74.6 vs. 88.9 %, p = .008; 51.1 vs. 71.9 %, p = .005). Grade 2 hypothyroidism was more common in the IE group (13.2 vs. 3.4 %, p = .029). For patients with T4 classification NPC after IMRT, patients with intracranial extension need more attention to the thyroid gland function and are more likely to experience local failure and death than patients without intracranial extension.

Entities:  

Keywords:  IMRT; Intracranial extension; Nasopharyngeal carcinoma; Survival; Toxicity

Mesh:

Year:  2015        PMID: 26282900     DOI: 10.1007/s00405-015-3749-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  Wai Tong Ng; Michael C H Lee; Wai Man Hung; Cheuk Wai Choi; Kin Chung Lee; Oscar S H Chan; Anne W M Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-06       Impact factor: 7.038

2.  Prognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment.

Authors:  Lei Chen; Li-Zhi Liu; Mo Chen; Wen-Fei Li; Wen-Jing Yin; Ai-Hua Lin; Ying Sun; Li Li; Jun Ma
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-31       Impact factor: 7.038

3.  Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma.

Authors:  Shuang Huang; Xiaosheng Wang; Chaosu Hu; Hongmei Ying
Journal:  Med Oncol       Date:  2013-09-03       Impact factor: 3.064

4.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

Review 5.  Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.

Authors:  Anne W M Lee; Wai Tong Ng; Lucy L K Chan; Wai Man Hung; Connie C C Chan; Henry C K Sze; Oscar S H Chan; Amy T Y Chang; Rebecca M W Yeung
Journal:  Radiother Oncol       Date:  2014-03-11       Impact factor: 6.280

6.  Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.

Authors:  Edmond H N Pow; Dora L W Kwong; Anne S McMillan; May C M Wong; Jonathan S T Sham; Lucullus H T Leung; W Keung Leung
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-15       Impact factor: 7.038

7.  Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma.

Authors:  Skye Hongiun Cheng; Stella Y C Tsai; K Lawrence Yen; James Jer-Min Jian; An-Chen Feng; Kwan-Yee Chan; Cheng-Fang Hong; Nei-Min Chu; Yen-Chun Lin; Chin-Yen Lin; Tran-Der Tan; Cheng-Yee Hsieh; Vincent Chong; Andrew T Huang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-02-01       Impact factor: 7.038

8.  Hypothyroidism after radiotherapy for nasopharyngeal cancer patients.

Authors:  Yuan-Hua Wu; Hung-Ming Wang; Hellen Hi-Wen Chen; Chien-Yu Lin; Eric Yen-Chao Chen; Kang-Hsing Fan; Shiang-Fu Huang; I-How Chen; Chun-Ta Liao; Ann-Joy Cheng; Joseph Tung-Chieh Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-15       Impact factor: 7.038

9.  Evaluation of clinical hypothyroidism risk due to irradiation of thyroid and pituitary glands in radiotherapy of nasopharyngeal cancer patients.

Authors:  Zhixiong Lin; Xiaoyan Wang; Wenjia Xie; Zhining Yang; Kaijun Che; Vincent W C Wu
Journal:  J Med Imaging Radiat Oncol       Date:  2013-05-16       Impact factor: 1.735

10.  Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

Authors:  Michael K M Kam; Sing-Fai Leung; Benny Zee; Ricky M C Chau; Joyce J S Suen; Frankie Mo; Maria Lai; Rosalie Ho; Kin-yin Cheung; Brian K H Yu; Samuel K W Chiu; Peter H K Choi; Peter M L Teo; Wing-hong Kwan; Anthony T C Chan
Journal:  J Clin Oncol       Date:  2007-11-01       Impact factor: 44.544

View more
  1 in total

1.  Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era.

Authors:  Sarbani Ghosh-Laskar; Avinash Pilar; Carlton Johnny; Kumar Prabhash; Amit Joshi; Jai Prakash Agarwal; Tejpal Gupta; Ashwini Budrukkar; Vedang Murthy; Monali Swain; Vanita Noronha; Vijay Maruthi Patil; Prathamesh Pai; Deepa Nair; Devendra Arvind Chaukar; Shivakumar Thiagarajan; Gouri Pantvaidya; Anuja Deshmukh; Pankaj Chaturvedi; Sudhir Nair; Anil D'Cruz
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.